Medicare Advantage plans are based on an enrollee's diagnosis; those with more serious or chronic conditions receive higher payments.

The Trump administration has put in motion its plan to secure lower prescription drug costs for Americans. This week, the Trump administration took its first steps to implement what’s called "most-favored-nation" pricing.

President Donald Trump and his White House have repeatedly vowed to protect Medicare and block any cuts to the vital health care program that serves 67 million Americans—most of them seniors. But according to top Democrats citing a report from the Congressional Budget Office,

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

Medicaid might not be the “third rail” of American politics in the way that Social Security benefits are, but it could be the proverbial Costco hot dog.

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying the prices of certain Medicare-covered drugs to those paid by other developed countries.

A federal judge has blocked a Trump administration decision to revoke Harvard University’s ability to enroll international students.

Nonpartisan research groups studying the proposal have estimated that it would add more than $2.5 trillion to the federal debt—currently at an all-time high of $36.8 trillion—over the next decade. Despite those projections,